Discrepancies between observed and predicted continuous venovenous hemofiltration removal of antimicrobial agents in critically ill patients and the effects on dosing

Intensive Care Medicine

Volumn 32, Issue 12, 2006, Pages 2013-2019

  Bouman, Catherine S C ^a   Van Kan, Hendrikus J M ^a   Koopmans, Richard P ^a   Korevaar, Johanna C ^a   Schultz, Marcus J ^a   Vroom, Margreeth B ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Antimicrobial drugs; Clearance; Continuous venovenous hemofiltration; Critically ill; Sieving coefficient

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; FLUCLOXACILLIN; FLUCONAZOLE; METRONIDAZOLE; VANCOMYCIN;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANURIA; ARTICLE; CLINICAL ARTICLE; CLINICAL STUDY; CONTINUOUS HEMOFILTRATION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG PROTEIN BINDING; FEMALE; HUMAN; KIDNEY CLEARANCE; KIDNEY FAILURE; MACHINE; MALE; PREDICTION; RELIABILITY; ULTRAFILTRATION;

AGED; ANTI-INFECTIVE AGENTS; ANURIA; APACHE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMOFILTRATION; HUMANS; INTENSIVE CARE UNITS; METABOLIC CLEARANCE RATE; MIDDLE AGED;

EID: 33751505967     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-006-0397-x     Document Type: Article

References (27)

1. Mehrotra R, De Gaudio R, Palazzo M (2004) Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness. Intensive Care Med 30:2145-2156
2. Subach RA, Marx MA (1998) Drug dosing in acute renal failure: the role of renal replacement therapy in altering drug pharmacokinetics. Adv Ren Replace Ther 5:141-147
3. Reetze-Bonorden P, Bohler J, Keller E (1993) Drug dosage in patients during continuous renal replacement therapy. Pharmacokinetic and therapeutic considerations. Clin Pharmacokinet 24:362-379
4. Lau AH, Kronfol NO (1994) Determinants of drug removal by continuous hemofiltration. Int J Artif Organs 17:373-378
5. Bohler J, Donauer J, Keller F (1999) Pharmacokinetic principles during continuous renal replacement therapy: drugs and dosage. Kidney Int Suppl 72:S24-S28
6. Golper TA, Wedel SK, Kaplan AA, Saad AM, Donta ST, Paganini EP (1985) Drug removal during continuous arteriovenous hemofiltration: theory and clinical observations. Int J Artif Organs 8:307-312
7. Bugge JF (2001) Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patients. Acta Anaesthesiol Scand 45:929-934
8. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G (2000) Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356:26-30
9. Bouman C, Kan H, Schultz M, Vroom M (2005) The removal of antibiotics during continuous venovenous hemofiltration (CVVH) in critically ill patients with acute renal failure: measured versus estimated CVVH clearance (abstract). Crit Care 9:14
10. Clark WR, Ronco C (1999) CRRT efficiency and efficacy in relation to solute size. Kidney Int Suppl 72:S3-S7
11. Schetz M, Ferdinande P, Van den BG, Verwaest C, Lauwers P (1995) Pharmacokinetics of continuous renal replacement therapy. Intensive Care Med 21:612-620
12. Boereboom FT, Ververs FF, Blankestijn PJ, Savelkoul TJ, van Dijk A (1999) Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients. Intensive Care Med 25:1100-1104
13. Matzke GR, O'Connell MB, Collins AJ, Keshaviah PR (1986) Disposition of vancomycin during hemofiltration. Clin Pharmacol Ther 40:425-430
14. Yagasaki K, Gando S, Matsuda N, Kameue T, Ishitani T, Hirano T, Iseki K (2003) Pharmacokinetics and the most suitable dosing regimen of fluconazole in critically ill patients receiving continuous hemodiafiltration. Intensive Care Med 29:1844-1848
15. Joos B, Schmidli M, Keusch G (1996) Pharmacokinetics of antimicrobial agents in anuric patients during continuous venovenous haemofiltration. Nephrol Dial Transplant 11:1582-1585
16. Matzke GR, Frye RF, Joy MS, Palevsky PM (2000) Determinants of ceftazidime clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis. Antimicrob Agents Chemother 44:1639-1644
17. Traunmuller F, Schenk P, Mittermeyer C, Thalhammer-Scherrer R, Ratheiser K, Thalhammer F (2002) Clearance of ceftazidime during continuous venovenous haemofiltration in critically ill patients. J Antimicrob Chemother 49:129-134
18. Bellmann R, Egger P, Gritsch W, Bellmann-Weiler R, Joannidis M, Dunzendorfer S, Wiedermann C (2002) Pharmacokinetics of ciprofloxacin in patients with acute renal failure undergoing continuous venovenous haemofiltration: influence of concomitant liver cirrhosis. Acta Med Austriaca 29:112-116
19. Malone RS, Fish DN, Abraham E, Teitelbaum I (2001) Pharmacokinetics of levofloxacin and ciprofloxacin during continuous renal replacement therapy in critically ill patients. Antimicrob Agents Chemother 45:2949-2954
20. Muhl E, Martens T, Iven H, Rob P, Bruch HP (2000) Influence of continuous veno-venous haemodiafiltration and continuous veno-venous haemofiltration on the pharmacokinetics of fluconazole. Eur J Clin Pharmacol 56:671-678
21. Valtonen M, Tiula E, Neuvonen PJ (1997) Effect of continuous venovenous haemofiltration and haemodiafiltration on the elimination of fluconazole in patients with acute renal failure. J Antimicrob Chemother 40:695-700
22. Shah M, Quigley R (2000) Rapid removal of vancomycin by continuous veno-venous hemofiltration. Pediatr Nephrol 14:912-915
23. Uchino S, Cole L, Morimatsu H, Goldsmith D, Bellomo R (2002) Clearance of vancomycin during high-volume haemofiltration: impact of pre-dilution. Intensive Care Med 28:1664-1667
24. Meyer B, Ahmed eG, Delle KG, Locker GJ, Heinz G, Jaeger W, Thalhammer F (2003) How to calculate clearance of highly protein-bound drugs during continuous venovenous hemofiltration demonstrated with flucloxacillin. Kidney Blood Press Res 26:135-140
25. Cigarran-Guldris S, Brier ME, Golper TA (1991) Tobramycin clearance during simulated continuous arteriovenous hemodialysis. Contrib Nephrol 93:120-123
26. Matzke GR, Frye RF, Joy MS, Palevsky PM (2000) Determinants of ceftriaxone clearance by continuous venovenous hemofiltration and hemodialysis. Pharmacotherapy 20:635-643
27. Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818-829